RxDoctor Payments Data

Angela Gray, OD

Optometrist · Beaufort, NCNPI 1609813666

Payments from drug & device makers

$699in general payments, 2019–2025

Across 31 payments — averaging $22.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$196
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$111
  • Sun Pharmaceutical Industries Inc.$103
  • Optos, Inc.$74
  • Coopervision Inc.$60
  • Alcon$34
  • plus $121 from 5 others

What the payments were for

  • Food & beverage$67997%
  • Gifts$193%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$699 in reported general payments places this provider in the 35th percentile of 1,326 optometrist providers in North Carolina.

See all optometrist providers in North Carolina

Medicare billing

Part B allowed, 2024
$87,169
Medicare patients
397
Services billed
1,096

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine44$60,656
MieboPerfluorohexyloctane/Pf44$36,552
XiidraLifitegrast16$13,361
VyzultaLatanoprostene Bunod22$7,331
Bepotastine Besilate41$6,199
CombiganBrimonidine Tartrate/Timolol14$2,722
Tobramycin-DexamethasoneTobramycin/Dexamethasone17$1,118
Prednisolone Acetate19$897
Latanoprost93$861
Timolol Maleate54$616

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRestasis, Combigan$33$63,37858 claims
Bausch & Lomb Americas Inc.Miebo, Xiidra, Vyzulta$196$57,24582 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 1,326 optometrist providers in North Carolina.

Other optometrist in Beaufort

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →